case_images: PMC6027982_01
case_images: Panitumumab-induced fatal ILD. MRI liver, March 2016 (A, B, C) and September 2016 (A1, BA, C1).
case_images: can-12-841fig1.jpg
case_images: PMC6027982_01_can-12-841fig1.jpg
case_images: figure1
case_images: Only two lesions had been identified in the liver MRI while the rest of the lesions disappeared (Figure 1).
case_images: Panitumumab-induced fatal ILD. Chest X-ray on day 1 of admission, showing mild interstitial shadowing in both lungs.
case_images: can-12-841fig2.jpg
case_images: PMC6027982_01_can-12-841fig2.jpg
case_images: figure2
case_images: Serial chest X-rays (Figures 2 and 3) showed diffuse reticulonodular shadowing.
case_images: Panitumumab-induced fatal ILD. Chest X-ray on day 17 of admission, showing further deterioration.
case_images: can-12-841fig3.jpg
case_images: PMC6027982_01_can-12-841fig3.jpg
case_images: figure3
case_images: Serial chest X-rays (Figures 2 and 3) showed diffuse reticulonodular shadowing.
case_images: Panitumumab-induced fatal ILD. HRCT of the chest, axial image, two days after the admission, showing bilateral patchy ground glass changes.
case_images: can-12-841fig4.jpg
case_images: PMC6027982_01_can-12-841fig4.jpg
case_images: figure4
case_images: High-resolution computed tomography (HRCT) (Figure 4) showed nonspecific interstitial pneumonia.